109 related articles for article (PubMed ID: 26671829)
1. Study of antibody repertoires to the CD4 binding site of gp120 of a Chinese HIV-1-infected elite neutralizer, using 454 sequencing and single-cell sorting.
Li D; Wang Z; Ren L; Zhang J; Feng G; Hong K; Hao Y; Qi Z; Liang H; Shao Y
Arch Virol; 2016 Apr; 161(4):789-99. PubMed ID: 26671829
[TBL] [Abstract][Full Text] [Related]
2. Reconstitution and characterization of antibody repertoires of HIV-1-infected "elite neutralizers".
Sun Z; Li J; Hu X; Shao Y; Zhang MY
Antiviral Res; 2015 Jun; 118():1-9. PubMed ID: 25770672
[TBL] [Abstract][Full Text] [Related]
3. Near-Pan-neutralizing, Plasma Deconvoluted Antibody N49P6 Mimics Host Receptor CD4 in Its Quaternary Interactions with the HIV-1 Envelope Trimer.
Tolbert WD; Nguyen DN; Tehrani ZR; Sajadi MM; Pazgier M
mBio; 2021 Aug; 12(4):e0127421. PubMed ID: 34281393
[TBL] [Abstract][Full Text] [Related]
4. Selection pressure on HIV-1 envelope by broadly neutralizing antibodies to the conserved CD4-binding site.
Wu X; Wang C; O'Dell S; Li Y; Keele BF; Yang Z; Imamichi H; Doria-Rose N; Hoxie JA; Connors M; Shaw GM; Wyatt RT; Mascola JR
J Virol; 2012 May; 86(10):5844-56. PubMed ID: 22419808
[TBL] [Abstract][Full Text] [Related]
5. Glycan Masking Focuses Immune Responses to the HIV-1 CD4-Binding Site and Enhances Elicitation of VRC01-Class Precursor Antibodies.
Duan H; Chen X; Boyington JC; Cheng C; Zhang Y; Jafari AJ; Stephens T; Tsybovsky Y; Kalyuzhniy O; Zhao P; Menis S; Nason MC; Normandin E; Mukhamedova M; DeKosky BJ; Wells L; Schief WR; Tian M; Alt FW; Kwong PD; Mascola JR
Immunity; 2018 Aug; 49(2):301-311.e5. PubMed ID: 30076101
[TBL] [Abstract][Full Text] [Related]
6. A broad range of mutations in HIV-1 neutralizing human monoclonal antibodies specific for V2, V3, and the CD4 binding site.
Li L; Wang XH; Williams C; Volsky B; Steczko O; Seaman MS; Luthra K; Nyambi P; Nadas A; Giudicelli V; Lefranc MP; Zolla-Pazner S; Gorny MK
Mol Immunol; 2015 Aug; 66(2):364-74. PubMed ID: 25965315
[TBL] [Abstract][Full Text] [Related]
7. Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing.
Wu X; Zhou T; Zhu J; Zhang B; Georgiev I; Wang C; Chen X; Longo NS; Louder M; McKee K; O'Dell S; Perfetto S; Schmidt SD; Shi W; Wu L; Yang Y; Yang ZY; Yang Z; Zhang Z; Bonsignori M; Crump JA; Kapiga SH; Sam NE; Haynes BF; Simek M; Burton DR; Koff WC; Doria-Rose NA; Connors M; ; Mullikin JC; Nabel GJ; Roederer M; Shapiro L; Kwong PD; Mascola JR
Science; 2011 Sep; 333(6049):1593-602. PubMed ID: 21835983
[TBL] [Abstract][Full Text] [Related]
8. Characterization of a VRC01-like antibody lineage with immature V
Hu Y; Li D; Yuan Z; Feng Y; Ren L; Hao Y; Wang S; Hu X; Liu Y; Hong K; Shao Y; Wang Z
Mol Immunol; 2023 Feb; 154():11-23. PubMed ID: 36577292
[TBL] [Abstract][Full Text] [Related]
9. An HIV-1 envelope immunogen with W427S mutation in CD4 binding site induced more T follicular helper memory cells and reduced non-specific antibody responses.
Yu HT; Tian D; Wang JY; Guo CX; Li Y; Wang X; Li D; Zhang FM; Zhuang M; Ling H
PLoS One; 2014; 9(12):e115047. PubMed ID: 25546013
[TBL] [Abstract][Full Text] [Related]
10. Identification of CD4-Binding Site Dependent Plasma Neutralizing Antibodies in an HIV-1 Infected Indian Individual.
Khan L; Makhdoomi MA; Kumar S; Nair A; Andrabi R; Clark BE; Auyeung K; Bhattacharya J; Vajpayee M; Wig N; Pantophlet R; Luthra K
PLoS One; 2015; 10(5):e0125575. PubMed ID: 25962059
[TBL] [Abstract][Full Text] [Related]
11. Structural mimicry of CD4 by a cross-reactive HIV-1 neutralizing antibody with CDR-H2 and H3 containing unique motifs.
Prabakaran P; Gan J; Wu YQ; Zhang MY; Dimitrov DS; Ji X
J Mol Biol; 2006 Mar; 357(1):82-99. PubMed ID: 16426633
[TBL] [Abstract][Full Text] [Related]
12. Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1.
Wu X; Yang ZY; Li Y; Hogerkorp CM; Schief WR; Seaman MS; Zhou T; Schmidt SD; Wu L; Xu L; Longo NS; McKee K; O'Dell S; Louder MK; Wycuff DL; Feng Y; Nason M; Doria-Rose N; Connors M; Kwong PD; Roederer M; Wyatt RT; Nabel GJ; Mascola JR
Science; 2010 Aug; 329(5993):856-61. PubMed ID: 20616233
[TBL] [Abstract][Full Text] [Related]
13. Maturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic Antibody.
Bonsignori M; Zhou T; Sheng Z; Chen L; Gao F; Joyce MG; Ozorowski G; Chuang GY; Schramm CA; Wiehe K; Alam SM; Bradley T; Gladden MA; Hwang KK; Iyengar S; Kumar A; Lu X; Luo K; Mangiapani MC; Parks RJ; Song H; Acharya P; Bailer RT; Cao A; Druz A; Georgiev IS; Kwon YD; Louder MK; Zhang B; Zheng A; Hill BJ; Kong R; Soto C; ; Mullikin JC; Douek DC; Montefiori DC; Moody MA; Shaw GM; Hahn BH; Kelsoe G; Hraber PT; Korber BT; Boyd SD; Fire AZ; Kepler TB; Shapiro L; Ward AB; Mascola JR; Liao HX; Kwong PD; Haynes BF
Cell; 2016 Apr; 165(2):449-63. PubMed ID: 26949186
[TBL] [Abstract][Full Text] [Related]
14. Identification of a novel broadly HIV-1-neutralizing antibody from a CRF01_AE-infected Chinese donor.
Ju B; Li D; Ren L; Hou J; Hao Y; Liang H; Wang S; Zhu J; Wei M; Shao Y
Emerg Microbes Infect; 2018 Nov; 7(1):174. PubMed ID: 30382080
[TBL] [Abstract][Full Text] [Related]
15. N463 Glycosylation Site on V5 Loop of a Mutant gp120 Regulates the Sensitivity of HIV-1 to Neutralizing Monoclonal Antibodies VRC01/03.
Wang W; Zirkle B; Nie J; Ma J; Gao K; Chen XS; Huang W; Kong W; Wang Y
J Acquir Immune Defic Syndr; 2015 Jul; 69(3):270-7. PubMed ID: 25751231
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of neutralization by the broadly neutralizing HIV-1 monoclonal antibody VRC01.
Li Y; O'Dell S; Walker LM; Wu X; Guenaga J; Feng Y; Schmidt SD; McKee K; Louder MK; Ledgerwood JE; Graham BS; Haynes BF; Burton DR; Wyatt RT; Mascola JR
J Virol; 2011 Sep; 85(17):8954-67. PubMed ID: 21715490
[TBL] [Abstract][Full Text] [Related]
17. HIV-1 receptor binding site-directed antibodies using a VH1-2 gene segment orthologue are activated by Env trimer immunization.
Navis M; Tran K; Bale S; Phad GE; Guenaga J; Wilson R; Soldemo M; McKee K; Sundling C; Mascola J; Li Y; Wyatt RT; Karlsson Hedestam GB
PLoS Pathog; 2014 Aug; 10(8):e1004337. PubMed ID: 25166308
[TBL] [Abstract][Full Text] [Related]
18. Temporal development and prognostic value of antibody response to the major neutralizing epitopes of gp120 during HIV-1 infection.
Turbica I; Simon F; Besnier JM; LeJeune B; Choutet P; Goudeau A; Barin F
J Med Virol; 1997 Jul; 52(3):309-15. PubMed ID: 9210041
[TBL] [Abstract][Full Text] [Related]
19. Structural basis for germline antibody recognition of HIV-1 immunogens.
Scharf L; West AP; Sievers SA; Chen C; Jiang S; Gao H; Gray MD; McGuire AT; Scheid JF; Nussenzweig MC; Stamatatos L; Bjorkman PJ
Elife; 2016 Mar; 5():. PubMed ID: 26997349
[TBL] [Abstract][Full Text] [Related]
20. The development of CD4 binding site antibodies during HIV-1 infection.
Lynch RM; Tran L; Louder MK; Schmidt SD; Cohen M; ; Dersimonian R; Euler Z; Gray ES; Abdool Karim S; Kirchherr J; Montefiori DC; Sibeko S; Soderberg K; Tomaras G; Yang ZY; Nabel GJ; Schuitemaker H; Morris L; Haynes BF; Mascola JR
J Virol; 2012 Jul; 86(14):7588-95. PubMed ID: 22573869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
